We supported a large pharmaceutical company in business plan and strategic initiatives development
The client is a large (top-10 Russian producer) Russian pharmaceutical company. The management team had been changed along with the changes in shareholders structure.
New management team needed to (1) continue the manufacturing processes, (2) identify the critical areas for management and operational improvements, (3) immediately develop a business plan with aspirational, but achievable KPIs for the new management team.
At the first stage MCG team analyzed the market situation, ran a set of interviews with the management and assessed the existing business processes within the organization.
Then the consultants prioritized the long list of potential areas for improvement collected through the stage 1. The prioritization was made based on potential effect and resources required.
As a result the list of top-priority strategic initiatives for the client was developed.
Finally, the financial model with operational and financial KPIs was developed.
Project results: (1) The new management team presented the business plan with the list of strategic initiatives to the Board of Directors; (2) the yearly KPIs for the management team were agreed on.